As of November 6, 2026, 5 holders' latest Schedule 13D or 13G filings report owning 5% or more of RxSight, Inc. The largest reported stake is BlackRock Portfolio Management LLC's, at 8.4%. 17 filings are on record since July 15, 2025 (Schedule 13G/A, October 27, 2026).
Sell to companies like RxSight, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Millennium Management LLC · Sole voting: 0 · Shared voting: 2,142,052 · Sole dispositive: 0 · Shared dispositive: 2,142,052 · SCHEDULE 13G/A, 2026-11-02
- · Reporting person: BlackRock Portfolio Management LLC · Sole voting: 3,082,879 · Shared voting: 0 · Sole dispositive: 3,491,612 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-27
- · Reporting person: BlackRock, Inc. · Sole voting: 2,782,168 · Shared voting: 0 · Sole dispositive: 2,851,023 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-27
- · Reporting person: Point72 Asset Management, L.P. · Sole voting: 0 · Shared voting: 2,487,468 · Sole dispositive: 0 · Shared dispositive: 2,487,468 · SCHEDULE 13G, 2026-08-19
- · Holder: Millennium Management LLC · Percent: 7.3% · SCHEDULE 13G/A
RxSight, Inc. has 17 Schedule 13D or 13G filings on record since 2025-07-15. 5 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 8.4% | 3,491,612 | SCHEDULE 13G/A, 2026-10-27 | 2026-09-30 |
| BlackRock, Inc. | 6.9% | 2,851,023 | SCHEDULE 13G/A, 2026-10-27 | 2026-09-30 |
| Point72 Asset Management, L.P. | 6% | 2,487,468 | SCHEDULE 13G, 2026-08-19 | 2026-08-12 |
| Millennium Management LLC | 5.1% | 2,142,052 | SCHEDULE 13G/A, 2026-11-02 | 2026-09-30 |
| Artisan Partners Asset Management Inc. | 5% | 2,058,684 | SCHEDULE 13G/A, 2026-05-13 | 2026-03-31 |
| Divisadero Street Capital Management, LP | 0.5% | 218,918 | SCHEDULE 13G/A, 2025-08-13 | 2025-06-30 |
| Bank Of America Corp | 0.4% | 172,091 | SCHEDULE 13G/A, 2025-08-13 | 2025-06-30 |
| RA Capital Management, L.P. | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind RxSight, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on RxSight, Inc. and the records around it.
RxSight, Inc. elsewhere on the record
- Leadership changes Jul 2026
- Who owns it
Companies that share a holder
- Artisan Partners Asset Management Inc. also filed stake reports on 16 other companies: Ascendis Pharma A/S (Aug 2026), AXALTA COATING SYSTEMS LTD. (Aug 2026), iRhythm Holdings, Inc. (Aug 2026)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026), PIMCO MUNICIPAL INCOME FUND II (Nov 2026)
Watch RxSight, Inc.
Get an email when RxSight, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on RxSight, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on RxSight, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RxSight, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 3,082,879 | 0 | 3,491,612 | 0 | SCHEDULE 13G/A, 2026-10-27 |
| BlackRock, Inc. | 2,782,168 | 0 | 2,851,023 | 0 | SCHEDULE 13G/A, 2026-10-27 |
| Point72 Asset Management, L.P. | 0 | 2,487,468 | 0 | 2,487,468 | SCHEDULE 13G, 2026-08-19 |
| Point72 Capital Advisors, Inc. | 0 | 2,487,468 | 0 | 2,487,468 | SCHEDULE 13G, 2026-08-19 |
| Steven A. Cohen | 0 | 2,487,468 | 0 | 2,487,468 | SCHEDULE 13G, 2026-08-19 |
| Millennium Management LLC | 0 | 2,142,052 | 0 | 2,142,052 | SCHEDULE 13G/A, 2026-11-02 |
| Millennium Group Management LLC | 0 | 2,142,052 | 0 | 2,142,052 | SCHEDULE 13G/A, 2026-11-02 |
| Israel A. Englander | 0 | 2,142,052 | 0 | 2,142,052 | SCHEDULE 13G/A, 2026-11-02 |
The latest filing identifies RxSight, Inc. by CUSIP 78349D107 and gives its principal executive office as 100 Columbia, Aliso Viejo, CA 92656 (SCHEDULE 13G/A, 2026-11-02).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-15 | Millennium Management LLC | 6.4% | SCHEDULE 13G |
| 2025-08-12 | Artisan Partners Asset Management Inc. | 5.5% | SCHEDULE 13G |
| 2025-08-13 | Bank Of America Corp | 0.4% | SCHEDULE 13G/A |
| 2025-08-13 | Divisadero Street Capital Management, LP | 0.5% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 5.8% | SCHEDULE 13G/A |
| 2025-11-04 | Millennium Management LLC | 5.4% | SCHEDULE 13G/A |
| 2025-11-12 | Artisan Partners Asset Management Inc. | 4.3% | SCHEDULE 13G/A |
| 2025-11-14 | RA Capital Management, L.P. | 0% | SCHEDULE 13G/A |
| 2026-02-03 | Artisan Partners Asset Management Inc. | 5.2% | SCHEDULE 13G |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-13 | Artisan Partners Asset Management Inc. | 5% | SCHEDULE 13G/A |
| 2026-07-17 | BlackRock Portfolio Management LLC | 7.2% | SCHEDULE 13G |
| 2026-08-04 | Millennium Management LLC | 7.3% | SCHEDULE 13G/A |
| 2026-08-19 | Point72 Asset Management, L.P. | 6% | SCHEDULE 13G |
| 2026-10-27 | BlackRock, Inc. | 6.9% | SCHEDULE 13G/A |
| 2026-10-27 | BlackRock Portfolio Management LLC | 8.4% | SCHEDULE 13G/A |
| 2026-11-02 | Millennium Management LLC | 5.1% | SCHEDULE 13G/A |
Questions about who owns RxSight, Inc.
Who owns RxSight, Inc.?
On this page, 5 holders' latest ownership filings report 5% or more of RxSight, Inc.: BlackRock Portfolio Management LLC (8.4%, Schedule 13G/A, filed 2026-10-27), BlackRock, Inc. (6.9%, Schedule 13G/A, filed 2026-10-27), Point72 Asset Management, L.P. (6%, Schedule 13G, filed 2026-08-19), Millennium Management LLC (5.1%, Schedule 13G/A, filed 2026-11-02) and Artisan Partners Asset Management Inc. (5%, Schedule 13G/A, filed 2026-05-13).
Who are the largest shareholders of RxSight, Inc.?
By the share each holder's latest filing reports, the largest holders of RxSight, Inc. on this page are BlackRock Portfolio Management LLC (8.4%), BlackRock, Inc. (6.9%) and Point72 Asset Management, L.P. (6%).
When did BlackRock Portfolio Management LLC buy into RxSight, Inc.?
The filings give report dates, not purchase dates. The earliest filing from BlackRock Portfolio Management LLC on this page is the Schedule 13G, filed 2026-07-17, reporting 7.2%; its latest, Schedule 13G/A filed 2026-10-27, reports 8.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 17 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for RxSight, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 15, 2026 | Leadership change: Aziz Mottiwala appointed, President and Chief Executive Officer, and 1 more | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for RxSight, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.